sirdalud tablett
sandoz pharmaceuticals d.d. - tisanidiin - tablett - 2mg 30tk
sirdalud tablett
sandoz pharmaceuticals d.d. - tisanidiin - tablett - 4mg 30tk
sirdalud tablett
ideal trade links uab - tisanidiin - tablett - 2mg 100tk; 2mg 30tk
sirdalud tablett
ideal trade links uab - tisanidiin - tablett - 4mg 30tk; 4mg 100tk
sirdalud tablett
ideal trade links uab - tisanidiin - tablett - 2mg 30tk; 2mg 100tk
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - kartsinoom, mitteväikerakk-kopsu - antineoplastilised ained - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
ciprofloxacin olainfarm õhukese polümeerikattega tablett
olainfarm as - tsiprofloksatsiin - õhukese polümeerikattega tablett - 250mg 100tk; 250mg 20tk; 250mg 10tk
ciprofloxacin olainfarm õhukese polümeerikattega tablett
olainfarm as - tsiprofloksatsiin - õhukese polümeerikattega tablett - 500mg 10tk; 500mg 20tk